Investors can make a fortune by investing in companies that get bought out. This is exactly what long term subscribers to The Arora Report have accomplished. There is no good reason why you too cannot accomplish the same thing.
The news is that biological testing products company Luminex Corporation (LMNX) has received a buyout offer.
The following post was just published in ZYX Buy Change Alert.
CONGRATULATIONS! LMNX BECOMES 165TH ARORA PORTFOLIO COMPANY TO BE BOUGHT OUT
Luminex Corporation (LMNX) is a biological testing products company.
LMNX has received a buyout offer from DiaSorin S.p.A. (DSRLF) of $37 per share cash. DiaSorin is an Italian company. LMNX is trading at $36.64 as of this writing.
LMNX has become 165th Arora Portfolio company to receive a buyout offer. The long time subscribers to The Arora Report have made a fortune from our propensity to identify companies that get bought out. This performance is significantly better than boutique services that charge upwards of $50,000.
What To Do Now
There is about a 25% probability of a higher offer. On the flip side, the company will need regulatory approvals. There is always a small risk that the deal may not close.
What to do now depends on personal preference. There is merit to taking profits but most investors may consider taking partial profits and continuing to hold the rest. For tracking purposes, partial profits will be taken and the rest will continue to be held.
To take a free 30-day trial to paid services to gain access to more opportunities, please click here.
This post was just published on ZYX Buy Change Alert.
Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES, TAKE A FREE
TRIAL TO PAID SERVICES.
